{"id":"W4402468317","doi":"10.1016/j.ejca.2024.114327","title":"Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial","year":2024,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pembrolizumab; Medicine; Placebo; Adjuvant; Melanoma; Oncology; Stage (stratigraphy); Internal medicine; Adjuvant therapy; Surgery; Immunotherapy; Cancer; Pathology; Cancer research; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002137929,0.001217147,0.002888951,0.0002449522,0.0003145366,0.00121225,0.000798435,0.001162742,0.003208942],"category_scores_gemma":[0.002098537,0.0004349357,0.002718498,0.0002987449,0.000727308,0.001011961,0.0004532138,0.003596944,0.0006202804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008992043,"about_ca_system_score_gemma":0.0007615159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001099064,"about_ca_topic_score_gemma":0.002219125,"domain_scores_codex":[0.9990538,0.0005709973,0.00003767052,0.0001266939,0.00005123239,0.0001596468],"domain_scores_gemma":[0.9990361,0.0003170004,0.0002304358,0.0001069071,0.000048666,0.0002609146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9787911,0.001246342,0.001178682,0.0003721893,0.002583002,0.00004592368,0.00003109611,0.0007587072,0.001892409,0.0001559012,0.0008173064,0.01212729],"study_design_scores_gemma":[0.8618956,0.1078213,0.01888927,0.0001607506,0.006022011,0.0000964803,0.00008930504,0.001676873,0.0007237262,0.0007749147,0.00180946,0.00004018466],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874321,0.007820144,0.0004332743,0.0007387516,0.0004730064,0.00029274,0.0008577722,0.00005239163,0.001899858],"genre_scores_gemma":[0.9947384,0.001394073,0.000292168,0.000477049,0.0002151454,0.0003018354,0.0008081613,0.00001367951,0.001759522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003208942,"threshold_uncertainty_score":0.01130658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02552894185840873,"score_gpt":0.3106194375100184,"score_spread":0.2850904956516097,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}